Why Is JPMorgan Chase & Co. (JPM) Up 1.7% Since Last Earnings Report? — Positive
JPM Zacks Investment Research — August 14, 2025JPMorgan Chase & Co. (JPM) reported earnings 30 days ago. What's next for the stock?
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Petco — Neutral
WOOF PRNewsWire — August 14, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Petco To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Petco between January 14, 2021 and June 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 14, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Petco Health and Wellness Company, Inc. …
John Deere reported third-quarter earnings Thursday that beat Wall Street estimates. Still, the agricultural machinery company said it took a $200 million hit from global tariffs in the quarter.
SuperCom Ltd. (SPCB) Q2 2025 Earnings Conference Call Transcript — Neutral
SPCB Seeking Alpha — August 14, 2025SuperCom Ltd. (NASDAQ:SPCB ) Q2 2025 Earnings Conference August 14, 2025 10:00 AM ET Company Participants Ordan Trabelsi - President & CEO Conference Call Participants Gregory Mesniaeff - Kingswood Capital Partners, LLC, Research Division Matthew Evan Galinko - Maxim Group LLC, Research Division Operator Ladies and gentlemen, good morning, and welcome to SuperCom's Second Quarter 2025 Financial Results and Corporate Update Conference Call.
H&R Real Estate Investment Trust (HRUFF) Q2 2025 Earnings Call Transcript — Neutral
HR HRUFF Seeking Alpha — August 14, 2025H&R Real Estate Investment Trust (OTCPK:HRUFF) Q2 2025 Earnings Conference Call August 14, 2025 9:30 AM ET Company Participants Emily Watson - Chief Operating Officer of Lantower Residential Larry Froom - Chief Financial Officer Matthew Kingston - Executive Vice President of Development & Construction Thomas J. Hofstedter - CEO & Executive Chairman Conference Call Participants Frederic Blondeau - Green Street Advisors, LLC, Research Division Khing Shan - RBC Capital Markets, Research Division Mario Saric - Scotiabank Global Banking and Markets, Research Division Matt Kornack - National Bank Financial, Inc., Research Division Sam Damiani - TD Cowen, Research Division Tal Woolley …
Allot Ltd. (NASDAQ:ALLT ) Q2 2025 Earnings Conference Call August 14, 2025 9:00 AM ET Company Participants Eyal David Harari - CEO & President Liat Nahum - Chief Financial Officer Conference Call Participants Jonathan Frank Ho - William Blair & Company L.L.C., Research Division Matthew Ryan Calitri - Needham & Company, LLC, Research Division Nehal Sushil Chokshi - Northland Capital Markets, Research Division Shaul Eyal - TD Cowen, Research Division Kenny Green - Unidentified Company Kenny Green Good day to all of you and welcome to Allot's conference call to discuss its financial results for the second quarter of 2025.
Cloudastructure and Flex Security's Mobile Surveillance Trailer Alpha™ Wins “Project Management Solution of the Year” at 2025 PropTech Breakthrough Awards; Recognized as Breakthrough Innovation in Construction Security — Neutral
CSAI GlobeNewsWire — August 14, 2025Proptech Breakthrough Awards PALO ALTO, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cloudastructure, Inc. (Nasdaq: CSAI) (“we,” “us,” “our,” “Cloudastructure” or the “Company”) an award-winning leader in AI Surveillance and Remote Guarding, today announced that its Alpha™ platform—developed in partnership with Flex Security, a division of RVMP®—has been named “Project Management Solution of the Year” for construction in the 5th Annual PropTech Breakthrough Awards. The program, conducted by PropTech Breakthrough, a leading independent market intelligence organization, recognizes the world's most innovative real estate technology companies and solutions.
LiveOne (Nasdaq: LVO) Launches Bitcoin Partnership with ARCA Utilizing $10.2M Capital Raise — Neutral
LVO GlobeNewsWire — August 14, 2025LOS ANGELES, Aug. 14, 2025 (GLOBE NEWSWIRE) -- LiveOne (Nasdaq: LVO), an award-winning, creator-first music, entertainment, and technology platform, today announced that it has purchased Bitcoin as part of the company's previously announced crypto long-term treasury yield management strategy.
Securities Fraud Investigation Into Celanese Corporation (CE) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz — Neutral
CE Business Wire — August 14, 2025LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Celanese Corporation (“Celanese” or the “Company”) (NYSE: CE) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CELANESE CORPORATION (CE), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On November 4, 2024, after market hours, Celanese reported its thir.
Amazon's Ad Business Hits Milestone: Is it the Next Revenue Pillar? — Positive
AMZN Zacks Investment Research — August 14, 2025AMZN's ad revenues gain 23% in Q2 2025 to $15.69B, fueled by AI, retail media, CTV growth and Prime Video's global ad rollout.
Sarepta Sells Arrowhead Stake to Fund Milestone Payment — Positive
SRPT Zacks Investment Research — August 14, 2025Sarepta sells $174M in Arrowhead shares to fund a $100M milestone payment as part of its RNAi drug collaboration.
Can Chipotle's New Menu Innovations Revive Comp Sales Momentum? — Positive
CMG Zacks Investment Research — August 14, 2025CMG is banking on new hits like Honey Chicken and Adobo Ranch to revive comp sales after a sluggish start to 2025.
Cellectar Biosciences, Inc. (CLRB) Q2 2025 Earnings Call Transcript — Neutral
CLRB Seeking Alpha — August 14, 2025Cellectar Biosciences, Inc. (NASDAQ:CLRB ) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Company Participants Chad J. Kolean - VP, CFO & Secretary James V.
How to Play BTM Stock Post Solid Q2 Results Amid Kiosk Expansion — Positive
BTM Zacks Investment Research — August 14, 2025Is Bitcoin Depot's 183% profit surge, kiosk growth and discounted valuation a signal to buy the stock now? Let's check it out.
Tapestry Q4 Earnings & Sales Top Estimates, Gross Margin Grows Y/Y — Positive
TPR Zacks Investment Research — August 14, 2025TPR's posts robust Q4 results as Coach fuels growth, digital sales climb and global markets deliver strong gains.
Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y — Negative
ARAY Zacks Investment Research — August 14, 2025ARAY stock down after Q4 earnings miss estimates, with product sales hit by tariffs and regional demand softness.
Top Stock Movers Now: Tapestry, Deere, Eli Lilly, and More — Negative
TPR DE LLY Investopedia — August 14, 2025U.S. equities were lower at midday as wholesale inflation rose more than expected in July. The Dow Jones Industrial Average, S&P 500, and Nasdaq were all down.
CCL Industries Inc. (CCDBF) Q2 2025 Earnings Call Transcript — Neutral
CCDBF CCL CCLLF Seeking Alpha — August 14, 2025CCL Industries Inc. (OTCPK:CCDBF) Q2 2025 Earnings Conference Call August 14, 2025 7:30 AM ET Company Participants Geoffrey T. Martin - President, CEO & Director Sean P.
DEADLINE ALERT for SOC, LMT, NVO, and LINE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders — Neutral
NVO GlobeNewsWire — August 14, 2025LOS ANGELES, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Allogene's Q2 Loss Narrower Than Expected, Pipeline in Focus — Negative
ALLO Zacks Investment Research — August 14, 2025ALLO posts a narrower second-quarter 2025 loss. The company advances multiple CAR T programs targeting cancer and autoimmune diseases.